Grantryl 1 mg/1 ml & 3 mg/3 ml Injection

Grantryl 1 mg/1 ml & 3 mg/3 ml Injection

S4
PDF Leaflet Revision Date: 28 November 2022

API: Granisetron | Company: Acino Pharma

Clinical Summary

Quick overview from the medicine insert

Indication

Management of nausea and vomiting induced by chemotherapy, radiotherapy, and post-operative.

Dosage (summary)

Adults: 1-3 mg IV prior to chemotherapy/radiotherapy; max 9 mg/24h. PONV: 1 mg IV prior to anesthesia.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated during pregnancy and lactation.

Key Drug Interactions

  • Phenobarbital may increase clearance
  • Co-administer with benzodiazepines and neuroleptics

Contraindications

  • Hypersensitivity
  • Children under 2 years
  • Congenital long QT syndrome

Common side effects

  • Headache
  • Dizziness
  • Somnolence
  • Abdominal pain
  • Constipation

Counselling Points

  • Avoid driving if somnolence occurs
  • Report any signs of myocardial ischemia

Serious warnings

  • May cause dysrhythmias
  • Monitor for myocardial ischemia
  • Max 9 mg/24h

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Grantryl 1 mg/1 ml & 3 mg/3 ml Injection
1/-

Connecting to Document Server

Decrypting and optimizing pharmaceutical leaflet...

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW